tm logo
ELATIVE
Live/Registered
REGISTERED

on 29 Mar 2022

Last Applicant/ Owned by

F-59120 LOOS

FR

Serial Number

79312182 filed on 20th Jan 2021

Registration Number

6681657 registered on 29th Mar 2022

in the Principal Register

Correspondent Address

Brooks R. Bruneau

Brooks R. Bruneau

Second Floor

100 Overlook Center

Princeton NJ 08540

Filing Basis

No Filing Basis

Disclaimer

NO DATA

ELATIVE

Pharmaceutical preparations for the prevention and treatment of liver diseases, cholestatic diseases, metabolic diseases, cancer diseases, inflammatory diseases, autoimmune diseases and cancers; chemical preparations for medical or pharmaceutical use, namely for the prevention and treatment of liver diseases, cholestatic diseases, metabolic diseases, cancer diseases, inflammatory diseases, autoimm Read More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the prevention and treatment of liver diseases, cholestatic diseases, metabolic diseases, cancer diseases, inflammatory diseases, autoimmune diseases and cancers; chemical preparations for medical or pharmaceutical use, namely for the prevention and treatment of liver diseases, cholestatic diseases, metabolic diseases, cancer diseases, inflammatory diseases, autoimmune diseases and cancers; organic preparations for medical or pharmaceutical use, namely for the prevention and treatment of liver diseases, cholestatic diseases, metabolic diseases, cancer diseases, inflammatory diseases, autoimmune diseases and cancers; diagnostic preparations for medical use; diagnostic reagents for medical use

Class [042]
Computer & Software Services & Scientific Services


Scientific research for medical purposes; pharmaceutical research and development services; conducting clinical trials for pharmaceutical products for others, in particular conducting clinical trials for determining the efficacy and safety of elafibranor; conducting clinical trials for others to determine the efficacy and safety of pharmaceutical products in the treatment of primary biliary cholangitis (PBC); conducting scientific studies and analyses in the field of pharmaceuticals and medicines; scientific research and development, namely, providing information, results and data relating to scientific or medical research and development of pharmaceutical products, via an online searchable database; conducting clinical trials for others; pharmaceutical and biological product development and research services for third parties; conducting clinical research for others; evaluation of the efficacy of pharmaceutical products; clinical product development services

Mark Details


Serial Number

No 79312182

Mark Type

No Service Mark

Attorney Docket Number

No 04774.T980US

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
29th Jun 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08th May 2022NEW REPRESENTATIVE AT IB RECEIVED
29th Mar 2022REGISTERED-PRINCIPAL REGISTER
11th Jan 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11th Jan 2022PUBLISHED FOR OPPOSITION
10th Jan 2022NOTIFICATION PROCESSED BY IB
22nd Dec 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
22nd Dec 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
22nd Dec 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09th Dec 2021LAW OFFICE PUBLICATION REVIEW COMPLETED